Home    Back

 Drug    DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, Adalimumab

ABCDEFGH I JKLMNOPQRSTUVWXYZother

7 / 17,542 descriptions

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 Disease ID
 1  Combination product: mavrilimumab  Mavrilimumab  [1] D09930 💬  [1] CSF2RA 💬  [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer  [1] 41 💬 
 2  Mavrilimumab  Mavrilimumab  [1] D09930 💬  [1] CSF2RA 💬  [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer  [2] 41, 46 💬 
 3  Mavrilimumab 10 mg  Mavrilimumab  [1] D09930 💬  [1] CSF2RA 💬  [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer  [1] 46 💬 
 4  Mavrilimumab 100 mg  Mavrilimumab  [1] D09930 💬  [1] CSF2RA 💬  [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer  [1] 46 💬 
 5  Mavrilimumab 150 mg  Mavrilimumab  [1] D09930 💬  [1] CSF2RA 💬  [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer  [1] 46 💬 
 6  Mavrilimumab 30 mg  Mavrilimumab  [1] D09930 💬  [1] CSF2RA 💬  [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer  [1] 46 💬 
 7  Mavrilimumab 50 mg  Mavrilimumab  [1] D09930 💬  [1] CSF2RA 💬  [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer  [1] 46 💬